These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 42297)

  • 1. Selective resistance to togaviral superinfection in mice with tolerant lymphocytic choriomeningitis virus infection.
    Nguyen Hong Diet ; Libíková H
    Acta Virol; 1979 Sep; 23(5):385-92. PubMed ID: 42297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of an arenavirus by a togavirus in experimental acute double infection.
    Hong Diet N; Libíková H; Rajcáni J
    Acta Virol; 1978 Sep; 22(5):391-400. PubMed ID: 30264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral superinfection in cells carrying an arenavirus and/or a togavirus.
    Nguyen-hong-Diet ; Libíková H
    Acta Virol; 1978 Nov; 22(6):477-84. PubMed ID: 35946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental mixed infection with two tick-borne viruses and interferon-mediated interference.
    Libíková H; Rajcáni J
    Acta Virol; 1975 Jan; 19(1):1-9. PubMed ID: 235191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
    Thomsen AR; Volkert M; Marker O
    Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis].
    Fomina AN; Nosik NN; Bukata LA; Davydova AA; Barinskiĭ NF
    Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of the long-tailed field mouse (Apodemus sylvaticus) to tick-borne encephalitis virus infection.
    Kopecký J; Tomková E; Vlcek M
    Folia Parasitol (Praha); 1991; 38(3):275-82. PubMed ID: 1725516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal role of interferon in lymphocytic choriomeningitis virus-induced encephalitis.
    Pfau CJ; Gresser I; Hunt KD
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1827-30. PubMed ID: 6192206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
    Buchmeier MJ; Oldstone MB
    J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
    Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
    Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.